All tenders
75A50121C00077
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN
Office of Assistant Secretary for Preparedness and Response · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50121C00077
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN
- Source
- USASpending (Federal)
- Source ID
- usa-75A50121C00077
Details
- Location
- United States
Description
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN Awarded to: INTERNATIONAL AIDS VACCINE INITIATIVE INC. Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2021/09/30 12:00:00 AM UTC
- Closing date
- 2028/12/31 12:00:00 AM UTC
Estimated value
$95.6M USD
Classification
Normalized category
Healthcare & Medical